Yao Wang, MD, MS

Dr. Yao Wang has over 18 years of clinical development experience in the pharmaceutical industry. During her career, she has held positions of increasing responsibilities at both large pharmaceutical and emerging biotechnology companies, including Allergan, Kyowa Kirin, Celgene, and Amgen. She has successfully advanced clinical programs across immunology, hematology, oncology, and CNS, making significant contributions to multiple successful NDA and sNDA filings, including Otezla, Vraylar, and Nourianz. Dr. Wang received her Master of Medicine from Peking University Health Science Center (Beijing Medical University) and a Master of Science from the University of Notre Dame.